Clinical trial of stem cell-derived therapy for patients with Type 1 diabetes – News-Medical.net
|
Clinical trial of stem cell-derived therapy for patients with Type 1 diabetes
News-Medical.net Researchers at the University of California, San Diego School of Medicine, in partnership with ViaCyte, Inc., a San Diego-based biotechnology firm specializing in regenerative medicine, have launched the first-ever human Phase I/II clinical trial of a … |
